Integral Diagnostics Limited announced the acquisition of Specialist Radiology Group, Trinity MRI and Cavendish Radiology in Auckland, New Zealand.
The three businesses combined:
- Comprise the leading specialist radiology clinics in Auckland
- Employ and contract several of the nation’s leading specialists in musculoskeletal radiology and neuroradiology
- Have a projected EBITDA contribution of NZ$13m to NZ$14m (A$12m to A$13m1 ) for FY19
- A high growth business with strong margins
- Provides a premier platform for Integral Diagnostics to enter and grow in New Zealand
The key terms of the deal include:
- A purchase consideration of NZ$105m (A$97.65m1 ) on a cash and debt free basis, comprising NZ$80m (A$74.4m1 ) in cash and NZ$25m (A$23.25m1 ) in IDX equity
- 80% of the equity will be held in escrow for up to 5 years
- A five year staged earn-out for vendor radiologists based on earnings outperformance
The acquisition is expected to be completed in July 2018, subject to satisfaction of customary conditions
This strategic acquisition includes four clinics, employing 14 radiologists who work in both the public and private sector. The clinics are market leaders in providing complex modalities including MRI, CT and SPECT (nuclear medicine), which are high margin services positioned to experience significant future growth. The clinics are fitted with a state of the art and modern modality fleet.
Dr Ian Kadish, MD and CEO of Integral Diagnostics, said “We are proud to incorporate these four leading specialist radiology clinics into Integral Diagnostics. The group’s radiologists and staff represent a strong strategic and cultural fit with IDX’s doctor led operating model. Joining the New Zealand clinics with our Australian business will create a significant, best-in-class diagnostic imaging platform in a collegiate trans-Tasman partnership. The clinics have a demonstrated track record of achieving strong revenue growth at market-leading profitability and add significant value to IDX. We extend a very warm welcome to the New Zealand doctors and staff and look forward to partnering with them to further grow our combined business.”
Dr Quentin Reeves and Dr Maurice Moriarty said “We are extremely pleased to be partnering with Integral Diagnostics who we consider to be the leading provider of specialist radiology services in Australia. Together we will be able to realise multiple synergies across our practices and further enhance and expand our services for patients in New Zealand.”
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.